ICUI
ICU MEDICAL INC/DE
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$169.11
+1.64%Year over year
Reported trailing growth
- Revenue
- -9.0%
- EBITDA
- -23.2%
- EBIT
- +56.7%
- EPS
- +178.9%
- Free cash flow
- +150.3%
- Operating cash flow
- +70.3%
Forward estimates
Based on analyst estimates
- Revenue
- +4.2%
- EBITDA
- +157.7%
- EPS
- +666.0%
Three-year CAGR
- Revenue
- -0.7%
- EBITDA
- +17.3%
- EBIT
- +116.5%
- Net income
- +100.6%
- EPS
- +100.6%
- Free cash flow
- +12.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026